Hepatitis E vaccine HEV 239 significantly reduces the risk of symptomatic hepatitis E among individuals with chronic ...

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

While rheumatoid arthritis patients have a lower overall cancer incidence rate, they face higher post-cancer mortality.

Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...

A new study suggests that garlic consumption may increase the risk of atrophic gastritis in individuals with H. pylori ...

Discover a study where patients reported symptom relief as early as one week after starting treatment, with continued ...

A new deep learning model predicts which NSCLC patients will respond to immunotherapy, outperforming some traditional ...

A new study finds that cognitive decline in relapsing-remitting multiple sclerosis (RRMS) often occurs independently of ...

Gut microbiota composition may influence the efficacy and safety of chemo-immunotherapy in advanced non-small cell lung cancer. Read now.

A large U.S. study finds that annual COVID-19 boosters provide significant protection against severe illness but lose ...

A recent study suggests that GLP-1 receptor agonists (GLP-1RAs) may lower the risk of hematologic cancers, including leukemia ...

A 12-month interim analysis of the AGILE Phase III extension study confirms the long-term safety and efficacy of twice-yearly ...